Clarification of vasculitis in Kawasaki disease; focusing on the endothelial microparticles
Project/Area Number |
15K09686
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Pediatrics
|
Research Institution | University of Toyama |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
高崎 一朗 富山大学, 大学院理工学研究部(工学), 准教授 (00397176)
山本 誠士 富山大学, 大学院医学薬学研究部(医学), 助教 (10456361)
伊吹 圭二郎 富山大学, 附属病院, 医員 (20566096)
市田 蕗子 富山大学, 事務局, 学長補佐 (30223100)
小澤 綾佳 富山大学, 附属病院, 診療助手 (40596540)
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2017: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2016: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2015: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | 川崎病 / 血管内皮微小粒子 / 血管炎 / 血管内皮細胞 / 微少粒子 |
Outline of Final Research Achievements |
EMPs could serve as a sensitive marker for characterizing the severity of endothelial damage and vasculitis in acute KD. Moreover, these specific miRs, hsa-miR-145-5p and hsa-miR-320a, may participate in modulation of inflammatory cytokine expression levels, and may contribute to pathogenesis of vasculitis in acute KD. Our novel findings might offer a new clinical approach for the treatment of KD. Further efforts are needed to develop the highly efficient molecular targeting therapies for KD.
|
Report
(4 results)
Research Products
(33 results)
-
-
-
-
-
[Journal Article] MicroRNA-145-5p and microRNA-320a encapsulated in endothelial microparticles contribute to the progression of vasculitis in acute Kawasaki Disease.2018
Author(s)
Nakaoka H, Hirono K, Yamamoto S, Takasaki I, Takahashi K, Kinoshita K, Takasaki A, Nishida N, Okabe M, Ce W, Miyao N, Saito K, Ibuki K, Ozawa S, Adachi Y, Ichida F.
-
Journal Title
Sci Rep.
Volume: 8
Issue: 1
Pages: 1016-1023
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] 5.Infliximab for the Treatment of Refractory Kawasaki Disease: A Nationwide Survey in Japan.2017
Author(s)
Masuda H, Kobayashi T, Hachiya A, Nakashima Y, Shimizu H, Nozawa T, Ogihara Y, Ito S, Takatsuki S, Katsumata N, Suzuki Y, Takenaka S, Hirono K, Kobayashi T, Suzuki H, Suganuma E, Takahashi K, Saji T
-
Journal Title
J Pediatr.
Volume: -
Pages: 115-120.e3
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Anomalous origin of the right coronary artery evaluated with multidetector computed tomography and its clinical relevance.2016
Author(s)
Hirono K, Hata Y, Miyao N, Nakaoka H, Saito K, Ibuki K, Watanabe K, Ozawa S, Higuma T, Yoshimura N, Nishida N, Ichida F
-
Journal Title
J Cardiol
Volume: 68
Issue: 3
Pages: 196-201
DOI
Related Report
Peer Reviewed
-
[Journal Article] MicroRNA-93 may control vascular endothelial growth factor A in circulating peripheral blood mononuclear cells in acute Kawasaki Disease2016
Author(s)
Saito K, Nakaoka H, Takasaki I, Hirono K, Yamamoto S, Kinoshita K, Miyao N, Ibuki K, Ozawa S, Watanabe K, Bowles NE, Ichida F
-
Journal Title
Pediatr Res
Volume: 80
Issue: 3
Pages: 425-432
DOI
Related Report
Peer Reviewed / Int'l Joint Research / Acknowledgement Compliant
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-